膽息肉 (膽固醇) | Gallbladder Polyps (Cholesterol) (Flexi)

GB Polyps MRP
HK$0.00
In stock
1
Product Details
品牌 Brand: 科學+家 SCIENTIST HOME | 拜塞 BIOSCI

膽囊息肉

膽囊息肉是膽囊粘膜的隆起,突出到膽囊腔內。膽囊息肉在成人中的患病率估計在0.3%-12.3%之間。然而,只有5%的息肉被認為是“真正的”膽囊息肉,這意味著它們是惡性的或具有惡性潜能。診斷和監測膽囊息肉的主要放射學方法是經腹超聲檢查。然而,有證據表明,內鏡超聲等其他檢查方法可以提高診斷準確性。在本次審查過程中,將依次討論這些問題。現時的指南建議對大小大於等於10 mm的膽囊息肉行膽囊切除術,但當確定其他危險因素時,該閾值會降低。這種做法背後的證據質量相對較低。

以上概述了支持當前膽囊息肉治療指南的現有證據的差距。TAUS是現時膽囊息肉放射學檢查的主要方法。EUS和HRUS作為TAU的輔助手段已顯示出一些前景,但需要更多的工作來評估息肉的確切作用和種類,以提供診斷準確性。儘管10 mm及以上的息肉更可能是真息肉,但該準則將遺漏大量低於該閾值的真息肉,當假息肉大於10 mm時,也將不必要地進行膽囊切除術。將上述風險因素考慮在內以降低膽囊切除術的閾值無疑會减少10 mm以下息肉的漏診數量,但在不需要時也會進行膽囊切除術。尚未進行任何研究來評估遵循這些指南的影響,因此需要進行更大的回顧性和前瞻性病例系列,以評估根據當前指南治療膽囊息肉的成功率。 (1)

膽息肉(膽固醇結構) - 多學科研證復康方案

  • 藥物及其他醫療方案, 請遵醫從醫生建議
  • 飲食營養請依營養師指引
  • 運動及或心理輔導, 請參考各專家建議
  • 為免錯誤診斷及漏診, 請上傳最近一個月醫院的專業診斷報告

不適合使用:

  • 膽息肉大於1公分
  • 明顯發炎堵塞期內
  • 已有黃疸
  • 非膽固醇形成的膽息肉

可能適合的補充劑支援:

標準組合:

A) 試用時期: 1个月

  1. 醇脂膽酸 x 4瓶
  2. 酶素研究 x 1瓶
  3. 铁重金属螯合 x 2瓶

顯著進程: 約 1 ~ 4 個月

胆囊息肉(胆固醇结构)一般需要3~6个月(0.5~1厘米大小)才能溶解,平均每月脂肪溶解量约为15~25%;每月可进行血液化验,监测甘油三酯、胆固醇等指标的改善情况;每 3 个月进行一次超声波扫描。

生活配合:

  • 不能吃太飽,以8成飽肚為主
  • 碳水化合物食物儘量減少份量(減30%-50%)
  • 高脂、高膽固醇食物必須避開少吃
  • 记得吃早餐
  • 多喝白開水,每天2公升
  • 多吃膳食纖維食物
  • 戒掉夜宵習慣
  • 不適宜自行補充鈣及鐵等礦物質
  • 早睡早起,不要熬夜
  • 每天不少於1萬步中速步行

飲食注意/戒口:

  • 煎炸烤燒食物儘量少吃
  • 動物肝臟、血液等高鐵質食物不要吃

注意:

  • 為營養補充品,不能代替藥物。
  • 懷孕或哺乳期女士、嬰幼兒,請不要食用本品。
  • 如不瞭解問題原因或問題持續,請儘快諮詢醫生。

如你有任何疾病, 請遵照閣下醫生的完整醫療方案; 而是否使用多學科復康方案前, 你必須咨詢主診醫生的意見, 如果閣下的主診醫生不建議您加入補充劑調理組合, 請你不要使用。如果你需要尋求其他醫生作第二咨詢, 閣下可聯絡我們線上<無邊界醫生>或你自己城市內的其他專業醫生的再診斷。

__


Gallbladder Polyps
A gallbladder polyp is an elevation of the gallbladder mucosa that protrudes into the gallbladder lumen. Gallbladder polyps have an estimated prevalence in adults of between 0.3%-12.3%. However, only 5% of polyps are considered to be "true" gallbladder polyps, meaning that they are malignant or have malignant potential. The main radiological modality used for diagnosing and surveilling gallbladder polyps is transabdominal ultrasonography. However, evidence shows that other modalities such as endoscopic ultrasound may improve diagnostic accuracy. These are discussed in turn during the course of this review.

>

Current guidelines recommend cholecystectomy for gallbladder polyps sized 10 mm and greater, although this threshold is lowered when other risk factors are identified. The evidence behind this practice is relatively low quality. This review identifies current gaps in the available evidence and highlights the necessity for further research to enable better decision making regarding which patients should undergo cholecystectomy, and/or radiological follow-up.

>

The gaps in the available evidence to support the current guidelines on the management of gallbladder polyps are outlined above. TAUS is the current mainstay for radiological investigation of gallbladder polyps. EUS and HRUS have shown some promise as an adjunct to TAUS but more work is required to assess the exact role and the category of polyps that they may provide diagnostic accuracy. Although polyps of 10 mm and greater are more likely to be true polyps, this cut-off will miss a significant number of true polyps below this threshold and cholecystectomy will also be performed unnecessarily for pseudopolyps when they are greater than 10 mm. The factoring in of the risk factors discussed above to lower the threshold for cholecystectomy will no doubt decrease the number of missed true polyps in the under 10 mm category but cholecystectomy will also be performed when it is not required. No research has been performed to assess the impact of following these guidelines and therefore larger retrospective and prospective case series need to be performed to assess the success of managing gallbladder polyps as per the current guidelines. (1)

>

Multidisciplinary rehabilitation program for Gallbladder Polyps (Cholesterol)
  • Please follow doctor's advice on drugs and other medical plans.
  • Please follow nutritionist's guidance.
  • For sports or psychological counseling, please refer to the experts' suggestions.
  • In order to avoid misdiagnosis, please upload the latest health report from hospital (preferably dated within a month).

Not suitable for:

  • Polyps greater than 1 cm
  • Occurrence of inflammation and blockage
  • Jaundice
  • Gallbladder polyps not caused by cholesterol

Suggested supplements:

Standard combination:

A) Trial period: 1 month

  1. Cholipolysis Cholic Acid x 4 bottles
  2. Scienzyme Study x 1 bottle
  3. Iron Heavy Metals Chelation x 2 bottles

Significant progress: about 1 ~ 4 months

Gallbladder polyps (cholesterol structure) generally take about 3 to 6 months (0.5 to 1 cm in size) to dissolve, and the average monthly fat dissolution is about 15 to 25%. Blood test is suggested monthly to monitor the improvement of cholesterol, triglyceride and other indicators. Suggest to perform ultrasonic scanning every 3 months.

Lifestyle Cooperation:

  • Don't eat too full, suggest 80% full
  • Reduce intake of carbohydrate (by 30% to 50%)
  • Avoid or less intake of high fat and cholesterol foods
  • Be sure to eat breakfast
  • Drink plenty of boiled water, suggest 2 liters a day
  • Eat more dietary fiber food
  • Get rid of supper routine
  • Do not recommend supplementation of calcium, iron or other minerals
  • Go to bed early and get up early, don't stay up late
  • Daily brisk walking of not less than 10,000 steps
Dietary suggestion:
  • Eat less fried and roasted foods.
  • Avoid foods rich in iron such as liver and blood from animal sources.
Reminder:
  • It is a nutritional supplement and cannot replace drugs.
  • Not suitable for pregnant or lactating women, infants and young children.
  • If you do not know the cause of the problem or the problem persists, please consult your doctor as soon as possible.

__


本品等並非根據《藥劑業及毒藥條例》或《中醫藥條例》注册。任何對其提出的宣稱均不受此類登記評估的約束。本產品不用於診斷、治療或預防任何疾病。

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.

__


Ref / 參考文獻:

McCain RS, Diamond A, Jones C, Coleman HG. Current practices and future prospects for the management of gallbladder polyps: A topical review. World J Gastroenterol. 2018;24(26):2844-2852. doi:10.3748/wjg.v24.i26.2844


Save this product for later